Current and Future Developments in the Treatment of CD30+ Lymphomas
CD30 is a cell membrane protein expressed on the surface of a range of lymphomas, which has important diagnostic, pathogenic, and prognostic roles. The most common CD30+ lymphomas are Hodgkin’s lymphoma (HL) and anaplastic large cell lymphoma (ALCL), but other types of lymphoma also express CD30, al...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2015-11-01
|
| Series: | European Medical Journal Oncology |
| Subjects: | |
| Online Access: | http://emjreviews.com/wp-content/uploads/Current-and-Future-Developments-in-the-Treatment-of-CD30-Lymphomas.pdf |